Fig. 1 | Genetics in Medicine

Fig. 1

From: Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)

Fig. 1

Four-tier evidence-based categorization system for acquired copy-number abnormalities (CNAs) and copy-neutral loss of heterozygosity (CN-LOH) detected by chromosomal microarray analysis (CMA).CEBM Oxford Centre for Evidence-Based Medicine, COG Children’s Oncology Group, COSMIC Catalogue of Somatic Mutations in Cancer, IPSS International Prognostic Scoring System for myelodysplastic syndromes, NCCN National Comprehensive Cancer Network, WHO World Health Organization.

Back to article page